AHR and COVID-19: Nevertheless, prolonged or excessive AHR activation poses risks, including immune suppression, viral persistence, and tissue fibrosis, concerns particularly relevant in long COVID-19 (Torti et al., 2021; Giovannoni et al., 2020; van den Boga et al., 2015).